China SXT Pharmaceuticals, Inc. (SXTC) Total Assets by Year
China SXT Pharmaceuticals, Inc. closed fiscal year 2026 with $34.8M in total assets, $5.0M in total liabilities and $29.7M in shareholder equity. This represents an increase of 60.4% from the prior fiscal year. The table below carries 10 fiscal years, from 2017 to 2026, and the quarters China SXT Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SXTC Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2620-F | FY2520-F | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.8M+60.4% | $21.7M-6.3% | $23.1M-21.7% | $29.6M-11.9% | $33.5M-2.9% | $34.5M+59.2% | $21.7M+24.2% | $17.5M+128.1% | $7.7M | N/A |
| Total Liabilities | $5.0M-18.9% | $6.2M-32.3% | $9.2M-38.1% | $14.9M-13.2% | $17.1M-7.9% | $18.6M+51.1% | $12.3M+93.3% | $6.4M+45.5% | $4.4M | N/A |
| Total Equity | $29.7M+92.4% | $15.4M+10.8% | $13.9M-5.2% | $14.7M-8.7% | $16.1M+0.8% | $16.0M+69.8% | $9.4M-15.4% | $11.1M+238.1% | $3.3M+77.4% | $1.9M |
SXTC Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2620-F | Q2'2610-Q | Q4'2520-F | Q2'2510-Q | Q4'2420-F | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q2'2210-Q | Q4'2110-K | Q2'2110-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.8M+60.4% | $26.4M-15.0% | $21.7M-6.3% | $31.0M+112.5% | $23.1M-21.7% | $14.6M-34.2% | $29.6M-11.9% | $22.2M-2.2% | $33.5M-2.9% | $22.7M-5.7% | $34.5M+59.2% | $24.0M+4.3% |
| Total Liabilities | $5.0M-18.9% | $6.1M-61.7% | $6.2M-32.3% | $16.0M+67.8% | $9.2M-38.1% | $9.5M+30.4% | $14.9M-13.2% | $7.3M-17.9% | $17.1M-7.9% | $8.9M+60.8% | $18.6M+51.1% | $5.5M-52.5% |
| Total Equity | $29.7M+92.4% | $20.2M+34.6% | $15.4M+10.8% | $15.0M+196.2% | $13.9M-5.2% | $5.1M-65.1% | $14.7M-8.7% | $14.5M+5.5% | $16.1M+0.8% | $13.8M-25.5% | $16.0M+69.8% | $18.5M+62.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More China SXT Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was China SXT Pharmaceuticals, Inc.'s total assets in fiscal year 2026?
China SXT Pharmaceuticals, Inc. closed fiscal year 2026 with $34.8M in total assets, $5.0M in total liabilities and $29.7M in shareholder equity.
How fast is China SXT Pharmaceuticals, Inc.'s total assets growing?
China SXT Pharmaceuticals, Inc. (SXTC) total assets rose by 60.4% year over year, from $21.7M to $34.8M in fiscal year 2026.
What was China SXT Pharmaceuticals, Inc.'s total assets in the most recent quarter?
China SXT Pharmaceuticals, Inc. (SXTC) reported $34.8M in total assets in Q4 2026. This represents an increase of 60.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what China SXT Pharmaceuticals, Inc. (SXTC) reported on that line in every period on record.